About this trial
The goal of this observational study is to develop, implement, and evaluate a machine learning algorithm-based Hepatitis C Emergency Department (HepC-EnD) screening tool for use in emergency departments (EDs) to identify patients at high risk of hepatitis C virus (HCV) infection. HepC-EnD will be integrated into the University of Florida Health electronic health record (EHR) system as a best practice alert (BPA) pop-up for ED providers, notifying them of patients at high risk for HCV infection and recommending both HCV and human immunodeficiency virus (HIV) screening. Investigators aim to enhance the screening and diagnosis of individuals who may otherwise remain undiagnosed and untreated.
The implementation outcomes (e.g., usability) and effectiveness outcomes (e.g., HCV screening and diagnosis rates) of HepC-EnD targeted screening will be compared with universal screening (FOCUS) and conventional physician-initiated screening programs in EDs.
Eligibility criteria
Qualifiers
18-79 years of age
Disqualifiers
< 18 years of age
Medically unstable
Trial design
Treatments tested in this trial
- Physician-Initiated Screening (Conventional Screening)
- FOCUS (Universal Screening)
- HepC-EnD (Targeted Screening)
Treatment groups
Sponsors and collaborators
University of Florida
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator